Last reviewed · How we verify

NCT05972538

Clinical Performance and Stability of Different Types of Implant Supported Overdenture

Completed NA Last updated 2 August 2023
What this trial tests

NA trial testing Osstell ( Osstell AB, Goteborg, Sweden). in Complete Edentulism in 6 participants. Completed in 5 July 2023.

Timeline
1 April 2023
Primary endpoint
1 July 2023
5 July 2023

Quick facts

Lead sponsorNational Research Centre, Egypt
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment6
Start date1 April 2023
Primary completion1 July 2023
Estimated completion5 July 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

National Research Centre, Egypt — full company profile →

Who can join

Adults 40 to 60, male only, with Complete Edentulism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A Total number of 36 implants were installed in 6 patients having mandibular single denture. The patients were divided into two groups according to the definitive prosthesis. Group I received ball and socket retained mandibular implant overdenture while Group II received cement retained implant supported fixed bridges.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Complete Edentulism

Currently open trials in the same condition.

Other National Research Centre, Egypt trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05972538.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing